Tell us about UCSF and what sets your institution apart? The simple answer to that question would be it’s the scientific research coupled with our focus on practical healthcare. At the University of California, San...
Medtech veteran adds further quality, regulatory, and clinical experience FAYETTEVILLE, AR- VIC Technology Venture Development has announced the appointment of Laura Lyons, who brings 20 years of executive leadership...
Nob Hill Therapeutics' Executive Chairman Paul Atkins will be presenting at the Partnership Opportunities in Drug Delivery (PODD) conference during the DryNeb – Advancing Pulmonary Drug Delivery session on Friday,...
The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...
A promising approach for preventing cognitive and behavioral impairment following ischemic events such as cardiac arrest and stroke. Aurora, CO - Neurexis Therapeutics, Incorporated, announces it has been awarded a...
Nob Hill Therapeutics was selected as a finalist in the Redefining Early Stage Investments (RESI) Innovator’s Pitch Challenge (IPC). An opportunity for early-stage companies to gain exposure to conference attendees,...
The University of California San Francisco (UCSF) Health Awards has selected CardioWise, Inc. as a Quarterfinalist in the Hospital Diagnostics Category. The awards showcase the health tech industry, showcasing the best...
New company advances novel vaccines to better fight COVID-19 and other pathogens FORT COLLINS, CO - VIC Technology Venture Development, LLC (VIC), announced today the formation of Colorado-based Solaris Vaccines, Inc.,...
The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...
In the first half of 2021, we have seen a return to more normal operations across VIC and our portfolio of companies. Progress across VIC and our portfolio of companies in 2021 H1 has been strong. Click Here to download...
FEATURED RESOURCES
